Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer

BACKGROUND: Prolonged angiogenesis inhibition may improve treatment outcome in metastatic colorectal cancer (mCRC) patients. However, due to the complexity of the angiogenic pathways there is a lack of valid predictive biomarkers for anti-angiogenic agents. Here, we describe and optimize a procedure...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagman, Helga, Bendahl, Pär-Ola, Lidfeldt, Jon, Belting, Mattias, Johnsson, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310295/
https://www.ncbi.nlm.nih.gov/pubmed/30592740
http://dx.doi.org/10.1371/journal.pone.0209838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310295/
https://www.ncbi.nlm.nih.gov/pubmed/30592740
http://dx.doi.org/10.1371/journal.pone.0209838

Ejemplares similares